These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 698913)

  • 81. [Survival and therapy of multiple myeloma. Apropos of 56 observed cases].
    Locatelli F; Giovanelli E; Neretto G; Furno F; Pellerito R
    Minerva Med; 1979 Mar; 70(13):925-33. PubMed ID: 220567
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Results of plasmacytoma therapy of ALGB (acute leukemia group B)].
    Obrecht JP
    Hamatol Bluttransfus; 1976; 18():383-93. PubMed ID: 964714
    [No Abstract]   [Full Text] [Related]  

  • 83. [Therapeutic experiences in multiple myeloma].
    Sonntag R; Favre E; Martz G
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555
    [No Abstract]   [Full Text] [Related]  

  • 84. Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model.
    Ghanta VK; Cohen HJ; Silberman HR; Durant JR; Hiramoto RN
    Cancer Clin Trials; 1981; 4(2):135-41. PubMed ID: 7249251
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Treatment of multiple myeloma using vincristine, cyclophosphamide, melphalan and prednisone (VCMP). Long-term results in 63 patients].
    Bladé J; Urbano A; López Guillermo A; Rozman M; Rovira M; Montserrat E; Rozman C
    Sangre (Barc); 1990 Apr; 35(2):93-7. PubMed ID: 2363100
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract]   [Full Text] [Related]  

  • 87. [Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy].
    Uzuka Y; Saito Y; Takahashi H; Komatsu M; Ito T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2269-73. PubMed ID: 2735769
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
    Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
    Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
    [No Abstract]   [Full Text] [Related]  

  • 89. Vindesine therapy in melphalan-resistant multiple myeloma.
    Houwen B; Ockhuizen T; Marrink J; Nieweg HO
    Eur J Cancer (1965); 1981 Feb; 17(2):227-32. PubMed ID: 7262159
    [No Abstract]   [Full Text] [Related]  

  • 90. Standard treatment of multiple myeloma.
    Oken MM
    Mayo Clin Proc; 1994 Aug; 69(8):781-6. PubMed ID: 8035637
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myeloma.
    Ventura GJ; Barlogie B; Hester JP; Yau JC; LeMaistre CF; Wallerstein RO; Spinolo JA; Dicke KA; Horwitz LH; Alexanian R
    Bone Marrow Transplant; 1990 Apr; 5(4):265-8. PubMed ID: 1970939
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].
    Herman TS; Durie BG; Hutter JJ
    Cancer Chemother Pharmacol; 1982; 8(1):73-5. PubMed ID: 6954016
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma.
    Cuttner J; Wasserman LR; Martz G; Sonntag RW; Kyle RA; Silver RT; Spurr C; Harley JB; Wiernik PM; Cornwell GG; Falkson G; Glidewell O; Holland JF
    Med Pediatr Oncol; 1975; 1(3):207-16. PubMed ID: 1232529
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Bone healing in multiple myeloma with melphalan chemotherapy.
    Rodriguez LH; Finkelstein JB; Shullenberger CC; Alexanian R
    Ann Intern Med; 1972 Apr; 76(4):551-6. PubMed ID: 4640313
    [No Abstract]   [Full Text] [Related]  

  • 95. Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1974 Dec; 57(6):927-39. PubMed ID: 4611209
    [No Abstract]   [Full Text] [Related]  

  • 96. Weekly low-dose cyclophosphamide and alternate-day prednisone: an effective low toxicity regimen for advanced myeloma.
    Brandes LJ; Israels LG
    Eur J Haematol; 1987 Oct; 39(4):362-8. PubMed ID: 3691759
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High-dose chemoradiotherapy with syngeneic bone marrow transplantation for multiple myeloma: a case report and literature review.
    Wolff SN; McCurley TL; Giannone L
    Am J Hematol; 1987 Oct; 26(2):191-8. PubMed ID: 3310614
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
    Presant CA; Hillinger S; Klahr C
    Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Adriamycin plus alkylating agents in the treatment of metastatic breast cancer.
    Lokich JJ; Skarin AT; Mayer RJ; Henderson IC; Blum RH; Frei E
    Cancer; 1977 Dec; 40(6):2801-5. PubMed ID: 338136
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Combination chemotherapy for multiple myeloma.
    Alexanian R; Bonnet J; Gehan E; Haut A; Hewlett J; Lane M; Monto R; Wilson H
    Cancer; 1972 Aug; 30(2):382-9. PubMed ID: 5051662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.